Vivanza Biosciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

4.00

4.00

4.00

4.00

4.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

0.72

0.40

-0.17

-0.63

-0.73

Loan funds

Secured loans

3.26

6.56

1.68

0.18

0.18

Unsecured loans

-

-

-

-

-

Total

7.98

10.96

5.51

3.54

3.44

Uses of funds

Fixed assets

Gross block

0.06

0.02

-

0.01

-

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.03

0.02

-

-

-

Net block

0.03

-

-

0.01

-

Capital work-in-progress

-

-

-

-

-

Investments

1.91

1.91

1.91

1.91

1.91

Net current assets

Current assets, loans & advances

14.93

18.52

9.55

6.01

10.36

Less : current liabilities & provisions

8.89

9.48

5.96

4.39

8.84

Total net current assets

6.04

9.05

3.59

1.61

1.53

Miscellaneous expenses not written

-

-

-

-

-

Total

7.98

10.96

5.51

3.54

3.44

Notes:

Book value of unquoted investments

1.91

1.91

1.91

1.91

1.91

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

400.00

400.00

40.00

40.00

40.00